Virtue® European Study

Inclusion Criteria: * The subject has an estimated life expectancy of more than 5 years * The subject has confirmed stress urinary incontinence (SUI) through medical history, urodynamics, and/or physical exam for at least 6 months * The subject has intrinsic sphincter deficiency due to radical prostatectomy completed at least 1 year prior to implantation date * The subject has a good bladder function * The subject has failed non-invasive therapies, eg. Pelvic Floor/Kegel exercises, behavioral modification, or biofeedback, for at least 6 months * The subject is willing to have the Virtue® Male Sling implanted * The subject is able and willing to complete all follow-up visits and procedures indicated in this protocol Exclusion Criteria: * The subject is unable or unwilling to comply with all follow-up requirements according to the study protocol * The subject has an active urinary tract infection or active skin infection in region of surgery (temporary exclusion) * The subject has compromised immune systems or any other conditions that affect healing * The subject has serious bleeding disorders * The subject has an urinary incontinence that is not mainly a stress urinary incontinence * The subject has a stress urinary incontinence due to TransUrethral Resection or laser surgery of the Prostate (TURP) * The subject has incontinence due to neurogenic causes defined as multiple sclerosis, spinal cord/brain injury, CVA, detrusor-external sphincter dyssynergia, Parkinson's disease, or similar conditions * The subject had a previous implant (male sling, Artificial Urinary Sphincter) to treat stress urinary incontinence (previous implanted bulking agents are allowed) * The subject has undergone radiation, cryosurgery, or brachy therapy to treat prostate or other pelvic cancer within 6 months * The subject is likely to undergo radiation therapy within the next 3 months * The subject has a postvoid residual (PVR) \> or = 150mL * The subject has recently required transurethral instrumentation for urethral or urethro-vesical anatomosis stricture within the previous 6 months * The subject is enrolled in a concurrent clinical study of any treatment (drug or device) that could affect continence function without the sponsors' approval * The subject is deemed unfit for male sling implantation or participation in a research protocol as determined by the attending physician